Everything you need to know to stay updated on the financial market. Information, trend and graph in real time on the stock exchange quotations of the major stocks on world stock exchanges.
ISIN code: IT0004056880
Sector: Healthcare technology
Industry: Specific medical equipment
Amplifon shares are listed on the Italian market on the Milan stock exchange under the ticker AMP.
Look at the history of the quotation of the share on the Milan Stock Exchange
Company Description
Amplifon SpA is an Italian company that deals with design, application and marketing of hearing aids. The group's business is mainly focused on the sale of hearing aids and related services. These include the application and personalization of appliances, the sale of accessory products such as batteries, consumables and spare parts. Thanks to its equipment, it makes it possible to rediscover all the emotions of sounds. In particular, it markets a generation of invisible hearing amplifiers, small electronic instruments that receive, process and amplify sounds before transmitting them to the ear using advanced technology. The company operates through a network of approximately 11.000 points of sale in 28 countries and 5 continents. The distribution of its products is carried out all over the world through different franchises and shops including those in Holland, France, Canada, Great Britain, Switzerland, Spain, United States, Egypt, Australia, New Zealand, Germany and India. Amplifon has different brands well known such as Sonus, Miracle, Ear, Beter Horen and Dialogue.
Economic and financial analysis of the company
Amplifon SpA is an Italian company founded in Milan in 1950 by Algernon Charles Holland, a former English officer, who at the end of the Second World War decided to start a business specializing in the supply of hearing aids for the numerous hearing problems caused by the conflict. Amplifon over the years develops on the Italian market through outlets nationwide to become the industry leader in the distribution, sale and fitting of hearing aids. In 1971 the Amplifon Research and Studies Center (CRS), an independent body aimed at disseminating knowledge in the audiological and otological fields.
Over the years it has specialized more on personalized customer service, thanks also to technological progress by introducing the first fully digital hearing aids in Italy in 1996. In this period the company achieved a market share in Italy of over 40%.
He broadened his horizons with the establishment in 1992 of a company in Spain and later in Portugal. Through various acquisitions, Amplifon enters the market of Switzerland, Austria, France, the Netherlands and the United States.
Amplifon SpA was listed on the stock exchange on June 27, 2001.
In 2001 it also happens an agreement with Bardissi Medical for the Middle Eastern market. In 2002 he acquired in the USA Sonus Corporation and in 2003 the company National Hearing Centers, a company with outlets mainly located in large shopping centres. Over the years, other acquisitions took place in Europe and he bought 100% of the shares of National Hearing Care (NHC), in Australia, New Zealand and India. In 2012 it also entered the Turkish market through the acquisition of 51% of the company Maxton, and in Poland with the constitution of Amplifon Poland. In 2014 he arrived in Brazil through the acquisition of 51% of the company Direction of Ouvir. In 2016, it invested 80 million to acquire 170 stores, especially in Canada and Germany. In 2017, it invested another 110 million, taking over 300 stores including two chains in France and Portugal. In July 2018 he made the largest acquisition of the group; thanks to a loan from Unicredit, it takes over the Catalan company for the sum of 528 million euros gaes which had 600 points of sale in Spain, Portugal and Latin America.
In recent years, especially since 2015, the value of the stock on the stock market has more than tripled. The turnover in 2018 was 1,37 billion euros with a profit of 113,4 million.
Amplifon's shares are growing steadily. After the crash during the pandemic, stocks are back on track. They recorded their highest price ever on 8 February 2021, reaching €37 per share.
The latest news about Amplifon
Amplifon: 2023 budget approved, dividend at 0,29 euros per share and new buyback plan
The Amplifon Shareholders' Meeting gave the green light to the 2023 budget and the distribution of a stable dividend of 0,29 euros per share. The Assembly also deliberated on the other matters on the agenda
Hearing aids, skyrocketing prices and little transparency: the Antitrust is moving. Amplifon sells on the stock market
Antitrust investigation reports high prices, lack of transparency and difficulty in accessing hearing aids through the national health service in Italy. Codacons calls for action to stop the "hearing business". Amplifon ends up losing more than 5% on Piazza Affari
Stock market closes March 25th: Piazza Affari (+0,86%) once again queen of Europe in the wake of Saipem and Tim
Piazza Affari is once again the best stock exchange in Europe in a record quarter. The American stock markets, however, moved little
Amplifon: the new “Listening Ahead” sustainability plan launches
The plan is divided into 20 new objectives that embrace four macro-areas: Products & Services, People, Community and Ethics, with deadlines in 2026, 2028 and 2030. Here they are in detail
Amplifon closes 2023 with record results. Dividend at 0,29 euros. The stock is trading on the stock exchange
Consolidated revenues at 2,26 billion euros, up 10,2%. International expansion continues. For 2024 results still growing. The stock rises +6% on Piazza Affari